Email this article SENSITIVITY OF 2018 KAZAKHSTAN INFLUENZA TYPE B VIRUSES TO ANTIVIRAL DRUGS
- Authors: Lukmanova G.V.1, Klivleyeva N.G.1, Baimukhametova A.M.1, Ongarbayeva N.S.1, Kalkozhayeva M.K.1, Baiseiit S.B.1, Glebova T.I.1
-
Affiliations:
- LLP Sсientific Production Center for Microbiology and Virology, Almaty
- Issue: Vol 8, No 4 (2018)
- Pages: 531
- Section: VIRAL INFECTIONS MANAGED BY MEANS OF VACCINATION AT THE STAGE OF DESTRUCTION AND ELIMINATION
- URL: https://iimmun.ru/iimm/article/view/919
- DOI: https://doi.org/10.15789/2220-7619-2018-4-3.31
- ID: 919
Cite item
Full Text
Abstract
About the authors
G. V. Lukmanova
LLP Sсientific Production Center for Microbiology and Virology, Almaty
Author for correspondence.
Email: fake@neicon.ru
Kazakhstan
N. G. Klivleyeva
LLP Sсientific Production Center for Microbiology and Virology, Almaty
Email: fake@neicon.ru
Kazakhstan
A. M. Baimukhametova
LLP Sсientific Production Center for Microbiology and Virology, Almaty
Email: fake@neicon.ru
Kazakhstan
N. S. Ongarbayeva
LLP Sсientific Production Center for Microbiology and Virology, Almaty
Email: fake@neicon.ru
Kazakhstan
M. K. Kalkozhayeva
LLP Sсientific Production Center for Microbiology and Virology, Almaty
Email: fake@neicon.ru
Kazakhstan
S. B. Baiseiit
LLP Sсientific Production Center for Microbiology and Virology, Almaty
Email: fake@neicon.ru
Kazakhstan
T. I. Glebova
LLP Sсientific Production Center for Microbiology and Virology, Almaty
Email: fake@neicon.ru
Kazakhstan
Supplementary files
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).